Synthetic octapeptide researched for reducing wrinkle depth by modulating SNARE complex formation, mimicking a topical alternative to botulinum toxin.
Last Updated: May 2026
SNAP-8 is a synthetic octapeptide (acetyl-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂) researched as a topical alternative to botulinum toxin (Botox) for wrinkle reduction. It is an elongated version of the related cosmetic peptide Argireline (acetyl hexapeptide-8), with two additional amino acids proposed to enhance penetration and effect. SNAP-8 is widely used in cosmetic skincare products and is not used as an injectable in research or clinical contexts. It is not subject to FDA therapeutic regulation as a cosmetic ingredient.
SNAP-8 is a synthetic acetylated and amidated octapeptide that mimics the N-terminal region of SNAP-25, a SNARE complex protein essential for neurotransmitter vesicle docking and acetylcholine release at neuromuscular junctions. By competing with SNAP-25 binding at the SNARE complex, SNAP-8 is proposed to reduce facial muscle contractions and the dynamic wrinkles they produce — mimicking the mechanism of botulinum toxin but through topical application rather than injection. Evidence level: Cosmetic dermatology research; ingredient-level efficacy studies; not formal therapeutic Phase 2/3.
Cosmetic dermatology studies of SNAP-8 (often in 1–10% topical concentrations) have demonstrated modest improvements in dynamic wrinkle depth and skin texture parameters over weeks of consistent application. The magnitude of effect is substantially smaller than injectable botulinum toxin, but the topical/non-injection route is the principal value proposition. Effects are reversible with discontinuation. The compound is well-characterized in cosmetic ingredient science. Evidence level: Cosmetic dermatology studies (multiple); not formal therapeutic Phase 2/3.
SNAP-8 is an elongated structural analog of Argireline (acetyl hexapeptide-8), with two additional amino acids proposed to enhance penetration and effect. Compared to botulinum toxin (Botox), both peptides produce much smaller effects but offer non-injection route and reversibility.
| Compound | Mechanism | Route | Effect magnitude |
|---|---|---|---|
| SNAP-8 | SNARE complex mimic (acetyl octapeptide) | Topical | Modest, gradual |
| Argireline (acetyl hexapeptide-8) | SNARE complex mimic (acetyl hexapeptide) | Topical | Modest, gradual |
| Botulinum toxin (Botox) | Direct SNARE protein cleavage | Injection | Strong, weeks-duration |
SNAP-8 has an extensive cosmetic safety record with rare reports of contact dermatitis as the primary concern. The topical route limits systemic exposure substantially. As a cosmetic ingredient, formal therapeutic safety surveillance does not apply. Long-term safety at sustained cosmetic use is well-established. Evidence level: Extensive cosmetic safety record; formal therapeutic safety surveillance not applicable.
SNAP-8 is a cosmetic ingredient subject to cosmetic regulation in most jurisdictions, with no therapeutic approval status to discuss. It is widely incorporated into commercial cosmetic skincare products. SNAP-8 was not specifically included in the April 2026 FDA Category 2 removals because cosmetic-grade SNAP-8 is not subject to the 503A bulks list framework. Regulatory context in are peptides legal regulatory status by country.
SNAP-8 is widely sold across cosmetic and ingredient supply chains with substantial quality variance — concentration claims in finished products are not always accurate, and some commercial products labeled as containing SNAP-8 may contain lower concentrations or related but distinct peptides. Independent HPLC purity testing of bulk material and mass spectrometry identity confirmation are essential. Guidance in how-to-test-peptides hub.
Peptigrity purchases SNAP-8 vials anonymously at standard customer pricing, sends them to ISO-accredited third-party labs for HPLC and mass spectrometry analysis, and publishes the unedited certificate of analysis. Methodology in how we calculate trust scores.
SNAP-8 mimics the mechanism of botulinum toxin (interfering with SNARE complex function at neuromuscular junctions) but produces much smaller effects through topical application versus Botox's strong effects through direct injection. The trade-off is non-invasive route and reversibility versus magnitude of effect.
SNAP-8 is widely available in cosmetic products and is legal to purchase as a cosmetic ingredient in most jurisdictions. It is not regulated as a therapeutic compound. Country breakdown in peptide legal status guide.
SNAP-8 is an elongated structural analog of Argireline (acetyl hexapeptide-8) with two additional amino acids proposed to enhance penetration and effect. Both peptides target the same SNARE-complex mechanism with similar but not identical efficacy profiles.
For bulk ingredient material: independent third-party HPLC certificate of analysis with mass spectrometry identity confirmation. For finished cosmetic products: verification is generally not practical at the consumer level; choosing established cosmetic brands with quality control transparency is the standard approach.
No. Cosmetic SNAP-8 concentrations vary by product (typically 1–10% in commercial formulations). Peptigrity is an independent review platform, not a cosmetic recommendation authority. Cosmetic products follow manufacturer instructions.
No. The topical route and weaker mechanism of action mean SNAP-8 does not produce the muscle weakness that injectable botulinum toxin can. Side effects are limited to occasional contact dermatitis.
This section is for educational and informational purposes only and does not constitute medical advice. SNAP-8 is a cosmetic ingredient and is not regulated as a therapeutic compound. Always consult a qualified healthcare provider for skin concerns. Peptigrity is an independent review platform and does not sell, endorse, or recommend specific products or vendors.
Real protocols and questions from members — independent of vendors, never sponsored.
Sign in to ask a question.
Every submitted test helps the community verify purity across brands. Free, fast, independent.